{"organizations": [], "uuid": "59175567684546f08a33c123875aea05f9277382", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-granules-india-says-us-fda-issued/brief-granules-india-says-u-s-fda-issued-eir-for-units-facility-in-virginia-idUSFWN1QI08P", "country": "US", "domain_rank": 408, "title": "BRIEF-Granules India Says U.S. FDA Issued EIR For Unit's Facility In Virginia", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.999, "site_type": "news", "published": "2018-02-28T15:00:00.000+02:00", "replies_count": 0, "uuid": "59175567684546f08a33c123875aea05f9277382"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-granules-india-says-us-fda-issued/brief-granules-india-says-u-s-fda-issued-eir-for-units-facility-in-virginia-idUSFWN1QI08P", "ord_in_thread": 0, "title": "BRIEF-Granules India Says U.S. FDA Issued EIR For Unit's Facility In Virginia", "locations": [], "entities": {"persons": [], "locations": [{"name": "virginia", "sentiment": "none"}, {"name": "virginia", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "u.s. fda", "sentiment": "negative"}, {"name": "brief-granules india says u.s. fda issued eir for unit", "sentiment": "negative"}, {"name": "granules india ltd", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Granules India Ltd:\n* SAYS U.S. FDA ISSUED EIR FOR GRANULES PHARMA FACILITY IN CHANTILLY, VIRGINIA\n* SAYS FACILITY INSPECTED BY U.S. FDA IN DEC; THERE WAS ONE OBSERVATION\n* SAYS RESPONDED TO OBSERVATION WITHIN STIPULATED TIMEFRAME Source text - bit.ly/2oD9XWr Further company coverage:\n ", "external_links": ["http://bit.ly/2oD9XWr", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T15:00:00.000+02:00", "crawled": "2018-03-01T21:11:33.007+02:00", "highlightTitle": ""}